Search Results - "Nichols, Craig"

The Use of Unsigned Earnings Quality Measures in Tests of Earnings Management by HRIBAR, PAUL, CRAIG NICHOLS, D.

“…This paper examines the implications of using the absolute value of discretionary accruals when testing for earnings management. First, we analytically develop…”
Get full text

MicroRNAs as Biomarkers for Germ Cell Tumors by Nappi, Lucia, MD, PhD, Nichols, Craig, MD

“…Two clusters of microRNAs have been discovered highly expressed by seminoma and nonseminoma germ cell tumors. They are secreted in blood of patients with…”
Get full text

Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance by Kollmannsberger, Christian, Tandstad, Torgrim, Bedard, Philippe L, Cohn-Cedermark, Gabriella, Chung, Peter W, Jewett, Michael A, Powles, Tom, Warde, Padraig R, Daneshmand, Siamak, Protheroe, Andrew, Tyldesley, Scott, Black, Peter C, Chi, Kim, So, Alan I, Moore, Malcom J, Nichols, Craig R

“…To evaluate the performance of active surveillance as a management strategy in broad populations and to inform the development of surveillance schedules by…”
Get full text

Testicular Cancer: A Prototypic Tumor of Young Adults by Hayes-Lattin, Brandon, Nichols, Craig R

“…Testicular cancer is the most common solid tumor among males in the 20- to 39-year age range. Moreover, testicular cancer has unique biological associations,…”
Get full text

Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2 by BARTON, Debra L, HESHAN LIU, LOPRINZI, Charles L, DAKHIL, Shaker R, LINQUIST, Breanna, SLOAN, Jeff A, NICHOLS, Craig R, MCGINN, Travis W, STELLA, Philip J, SEEGER, Grant R, SOOD, Amit

“…Safe, effective interventions to improve cancer-related fatigue (CRF) are needed because it remains a prevalent, distressing, and activity-limiting symptom…”
Get full text

Publicly traded versus privately held: implications for conditional conservatism in bank accounting by Craig Nichols, D., Wahlen, James M., Wieland, Matthew M.

“…Compared with privately held banks, publicly traded banks face greater agency costs because of greater separation of ownership and control but enjoy greater…”
Get full text

Active surveillance is the preferred approach to clinical stage I testicular cancer by Nichols, Craig R, Roth, Bruce, Albers, Peter, Einhorn, Lawrence H, Foster, Richard, Daneshmand, Siamak, Jewett, Michael, Warde, Padraig, Sweeney, Christopher J, Beard, Clair, Powles, Tom, Tyldesley, Scott, So, Alan, Porter, Christopher, Olgac, Semra, Fizazi, Karim, Hayes-Lattin, Brandon, Grimison, Peter, Toner, Guy, Cathomas, Richard, Bokemeyer, Carsten, Kollmannsberger, Christian

Get full text

Management of Disseminated Nonseminomatous Germ Cell Tumors With Risk-Based Chemotherapy Followed by Response-Guided Postchemotherapy Surgery by KOLLMANNSBERGER, Christian, DANESHMAND, Siamak, SO, Alan, CHI, Kim N, MURRAY, Nevin, MOORE, Christie, HAYES-LATTIN, Brandon, NICHOLS, Craig

“…The management of patients with a radiographic complete response after chemotherapy remains controversial. The current study assesses the outcome for a modern,…”
Get full text

Patterns of Care and Survival Outcomes for Malignant Sex Cord Stromal Testicular Cancer: Results from the National Cancer Data Base by Banerji, John S, Odem-Davis, Katherine, Wolff, Erika M, Nichols, Craig R, Porter, Christopher R

“…Purpose Sex cord stromal tumors of the testis comprise less than 5% of testicular neoplasms. Consequently, data regarding patterns of care and survival are…”
Get full text

Phase III Randomized Trial of Conventional-Dose Chemotherapy With or Without High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Rescue As First-Line Treatment for Patients With Poor-Prognosis Metastatic Germ Cell Tumors by MOTZER, Robert J, NICHOLS, Craig J, BOSL, George J, MARGOLIN, Kim A, BACIK, Jennifer, RICHARDSON, Paul G, VOGELZANG, Nicholas J, BAJORIN, Dean F, LARA, Primo N, EINHORN, Lawrence, MAZUMDAR, Madhu

“…To investigate the role of high-dose chemotherapy (HDCT) as first-line treatment in patients with metastatic germ cell tumor (GCT) and poor-prognostic clinical…”
Get full text

Enhancing Adolescent and Young Adult Oncology Research Within the National Clinical Trials Network: Rationale, Progress, and Emerging Strategies by Weiss, Aaron R, Nichols, Craig R, Freyer, David R

“…Adolescent and Young Adult Oncology (AYAO, including patients 15–39 years of age) is an emerging discipline in the field of cancer treatment and research…”
Get full text

Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm by Tandstad, Torgrim, Kollmannsberger, Christian K, Roth, Bruce J, Jeldres, Claudio, Gillessen, Silke, Fizazi, Karim, Daneshmand, Siamak, Lowrance, William T, Hanna, Nasser H, Albany, Costantine, Foster, Richard, Cedermark, Gabriella Cohn, Feldman, Darren R, Powles, Thomas, Lewis, Mark A, Grimison, Peter Scott, Bank, Douglas, Porter, Christopher, Albers, Peter, De Santis, Maria, Srinivas, Sandy, Bosl, George J, Nichols, Craig R

Get full text

Testicular Cancer Survivorship: Research Strategies and Recommendations by Travis, Lois B., Beard, Clair, Allan, James M., Dahl, Alv A., Feldman, Darren R., Oldenburg, Jan, Daugaard, Gedske, Kelly, Jennifer L., Dolan, M. Eileen, Hannigan, Robyn, Constine, Louis S., Oeffinger, Kevin C., Okunieff, Paul, Armstrong, Greg, Wiljer, David, Miller, Robert C., Gietema, Jourik A., van Leeuwen, Flora E., Williams, Jacqueline P., Nichols, Craig R., Einhorn, Lawrence H., Fossa, Sophie D.

“…Testicular cancer represents the most curable solid tumor, with a 10-year survival rate of more than 95%. Given the young average age at diagnosis, it is…”
Get full text

Once Upon a Time…. Simple, Sensible Management of Venous Access for Chemotherapy Delivery in Germ Cell Tumors by Ozgun, Guliz, Haney, LaTrice, Kern, Sean, King, Jennifer, D'Souza, Anishka, Tandstad, Torgrim, Nappi, Lucia, Kollmannsberger, Christian, Nichols, Craig R

Get more information

Prophylaxis Against Thromboembolic Events During Chemotherapy for Germ Cell Cancer by Meng, Xiaosong, Ahmed, Murtaza, Courtney, Kevin D, Arafat, Waddah, Ibrahim, Ibrahim, Margulis, Vitaly, Nichols, Craig, Bagrodia, Aditya

“…Patients with advanced germ cell tumors (GCT) receiving cisplatin-based chemotherapy have high rates of thromboembolic events (TEE) which can negatively affect…”
Get full text

Reply to L.C. Pagliaro et al by Kollmannsberger, Christian K, Nichols, Craig R

Get full text

Classical clinical trial design in testicular cancer: time to move on by Nichols, Craig R, Roth, Bruce, Kollmannsberger, Christian

Get full text

Utilization of retroperitoneal lymph node dissection for testicular cancer in the United States: Results from the National Cancer Database (1998–2011) by Hugen, Cory M., M.D, Hu, Brian, M.D, Jeldres, Claudio, M.D, Burton, Claire, M.D, Nichols, Craig R., M.D, Porter, Christopher R., M.D, Daneshmand, Siamak, M.D

“…Abstract Introduction Retroperitoneal lymph node dissection (RPLND) for the treatment of testicular cancer is a relatively rare and complex operation that may…”
Get full text

Placebo-Controlled Phase III Trial of Patient-Specific Immunotherapy With Mitumprotimut-T and Granulocyte-Macrophage Colony-Stimulating Factor After Rituximab in Patients With Follicular Lymphoma by FREEDMAN, Arnold, NEELAPU, Sattva S, ESQUIBEL, Vanessa, HAMLIN, Paul, NICHOLS, Craig, ROBERTSON, Michael J, DJULBEGOVIC, Benjamin, WINTER, Jane N, BENDER, John F, GOLD, Daniel P, GHALIE, Richard G, STEWART, Morgan E

“…To evaluate patient-specific immunotherapy with mitumprotimut-T (idiotype keyhole limpet hemocyanin [Id-KLH]) and granulocyte-macrophage colony-stimulating…”
Get full text

New treatments for stage I testicular cancer by Nappi, Lucia, Nichols, Craig R, Kollmannsberger, Christian K

“…Clinical stage I represents the most frequent presentation of both seminoma and nonseminoma testicular cancer. Despite a survival rate of close to 100%, the…”
Get full text